← Human Trials & Peer-Reviewed Studies
Serum vitamin D levels in children with vernal keratoconjunctivitis - A study from a tertiary care pediatric hospital of North India.
Plain-language guide to PMID 38770629 (2024): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 38770629
- Journal
- Indian journal of ophthalmology
- Year
- 2024
- Study type
- Randomized Controlled Trial
- Authors
- Wadhwani M et al. (3 authors)
- DOI
- 10.4103/IJO.IJO_773_23
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
To study the levels of vitamin D serum levels in children with vernal keratoconjuctivits (VKC) and comparing vitamin D levels in after giving vitamin D supplements between intervention and control group.
Who Took Part
The age groups tagged for this paper are infants, young children and children, both men and women.
Amongst children with VKC, full ocular examination along with Boninis clinical grading of VKC and serum vitamin D levels were assessed.
How the Study Was Run
The design is described as randomized.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
The study was conducted in population between 1 to 12 years in tertiary care hospital in North India.
Whole study group was randomly divided into two groups.
Intervention group had received vitamin D powder while control group kept under observation.
What Was Measured
To study the levels of vitamin D serum levels in children with vernal keratoconjuctivits (VKC) and comparing vitamin D levels in after giving vitamin D supplements between intervention and control group.
The subject headings attached to it are India, Vitamin D, Conjunctivitis, Allergic, Tertiary Care Centers, Vitamins, Hospitals, Pediatric and Vitamin D Deficiency.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.
The abstract goes on to report its results in about 2 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2024 (Indian journal of ophthalmology), a journal based in India.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.